Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in Chinese men and women, 1990–2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in China in 2021. by Zhengpeng Li (2322058)

Subjects:

All–age cases and age–standardised incidence, prevalence, mortality, DALYs and corresponding AAPC for RA in China and world in 1990 and 2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in China in 1990. by Zhengpeng Li (2322058)

Subjects:

Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in global in 2021. by Zhengpeng Li (2322058)

Subjects:

APC of ASIR, ASPR, ASMR and ASDR for global RA from1990 to 2021. by Zhengpeng Li (2322058)

Subjects:

APC of ASIR, ASPR, ASMR and ASDR for China RA from 1990 to 2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in global in 1990. by Zhengpeng Li (2322058)

Subjects:

Burden and trends of LC in the chinese annual cancer registry in 2004 and 2018. by Ze-Xing Zhang (18074512)

Subjects:

EAPC in incidence and mortality of LC for age group. by Ze-Xing Zhang (18074512)

Subjects:

Cases and deaths of LC from the Chinese Annual Cancer Registry, 2004–2018. by Ze-Xing Zhang (18074512)

Subjects:

Changes in LC cases and deaths in male and female from 2004 to 2018, decomposed by three population-level determinants: population aging, population growth and epidemiological chan... by Ze-Xing Zhang (18074512)

Subjects:

Projected ASIR and ASMR of LC in China over the next 15 years based on the Bayesian APC model. by Ze-Xing Zhang (18074512)

Subjects:

The incidence and mortality data of LC by age group from the Chinese Annual Cancer Registry, 2004–2018. by Ze-Xing Zhang (18074512)

Subjects:

Contribution of changes in population aging, population growth, and age-specific incidence rate to changes in incident cases of LC from 2004 to 2018 in China. by Ze-Xing Zhang (18074512)

Subjects:

Minimal data set. by Pornpan Chalermkitpanit (22110121)

Subjects:

Univariate and multivariate analysis of variables associated with good and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

The correlation between clinical presentations and baseline serum inflammatory cytokines before TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

The serum concentrations of cytokines between good responders and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

Demographic data and baseline characteristics between good and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects: